Hillhouse HCare Global Healthcare Innovation Summit & Mayo Clinic China Healthcare Summit: A Landmark Event in Biopharma and Digital Health
In 2020, as the COVID-19 pandemic raged globally, the value of the medical and general health industry became increasingly prominent. How can we accelerate biotechnological innovation, enhance healthcare standards, and speed up the development of the broader health industry? The medical and healthcare sector bears an unshirkable responsibility. Against the backdrop of the historical imperative for upgrading the medical and healthcare industry, new opportunities for investment and entrepreneurship are gradually emerging.
From August 6 to August 10, 2020, the global health industry will witness a highlight moment.“The Hillhouse HCare Global Health Industry Summit & Mayo Clinic China Healthcare Summit”—two major industry events—will make their grand return via online live streaming (https://hillhousecare.com/).Leading clinical experts from top hospitals worldwide, innovative drug developers, policymakers, hospital administrators, industry researchers, top-tier investors, and entrepreneurs will convene here to share the most cutting-edge global advancements in medical care and pharmaceutical R&D, exchange advanced management philosophies and practices between China and abroad, and address the most pressing challenges facing the healthcare industry today.
The summit will bring together a stellar lineup of luminaries from the healthcare and medical sectors. Attendees include Wang Chen, Vice President of the Chinese Academy of Engineering, President of the Chinese Academy of Medical Sciences & Peking Union Medical College, and Academician of the Chinese Academy of Engineering; Huo Yong, Professor at Peking University First Hospital and President of the World Chinese Cardiologists Association; G. Anton Decker, President of Mayo Clinic International; and more than ten other experts and academicians in the fields of life sciences and medicine from China and abroad. Also joining are over ten global leaders, entrepreneurs, and pioneers in biotechnology from the healthcare innovation industry, including CEOs from Moderna and Alaylam; investors from renowned domestic and international investment firms; and distinguished scholars such as Professor Zhang Wenhong, Director of the Department of Infectious Diseases at Huashan Hospital Affiliated to Fudan University, who served on the front lines of the pandemic response. Their participation will culminate in a comprehensive “family portrait” of the healthcare industry.
The official registration portal for the summit is now live on its website. You can access it via the Chinese domain name “Hillhouse Hcare 2020 Global Health Industry Summit,” by directly entering https://hillhousecare.com/, or by scanning the QR code. Simply click “Register Now” to secure your spot and experience this premier event in the global health industry in one month.
“Hillhouse HCare Global Health Industry Summit & Mayo Clinic China Healthcare Summit” (https://hillhousecare.com/), jointly hosted by Hillhouse Capital, Mayo Clinic, and Huimei Medical Group, aims to bring together domestic and international experts to witness the pioneering forces in the global healthcare industry, discuss collaboration in the global health sector, frontier advances in innovative drug R&D, the construction of life science ecosystems, and look ahead to the next wave of disruptive innovation.
Since 2017, Hillhouse Capital, in collaboration with Mayo Clinic and Huimei Healthcare, has successfully co-hosted three editions of the “Mayo Clinic China Healthcare Summit,” an industry event that has consistently embraced a global perspective to facilitate the flow and integration of top-tier medical resources. The concurrent holding of this year’s Hillhouse HCare Global Health Industry Summit signifies a comprehensive upgrade and expansion of the original summit.
As the conference’s permanent IP, “HCare” signifies that Hillhouse will harness the power of its platform and leverage its capital advantages to empower the healthcare industry ecosystem. It is committed to addressing the dreams, needs, and aspirations of every scientist, physician, patient, and entrepreneur in the health sector, while fostering the prosperity and vibrant growth of the global healthcare industry ecosystem.
Furthermore, the concurrent holding of these two major summits will foster interaction and complementarity in terms of expert resources and agenda setting. By offering deeper industry insights, more comprehensive industrial coverage, and a broader global perspective, this event will deliver a premier feast of innovative ideas to attending guests.
The summit will feature one main forum and 15 thematic sub-forums. Based on the currently released agendas for the sub-forums, attendees will engage in dialogue and exchange on the most cutting-edge directions and latest innovative achievements in the global healthcare industry, including progress in the development of COVID-19 vaccines and therapeutic antibodies, precision therapy for hematologic malignancies and solid tumors, clinical application of cardiovascular interventional devices and medical technologies, and R&D of innovative drugs for rare diseases.
Among these events, the Mayo Clinic China Medical Summit is Mayo Clinic’s premier annual gathering, featuring the highest level of participation and the largest number of experts for exchange. This year, more than 15 distinguished guests attended, covering nine major thematic forums on cutting-edge topics across various fields.
These two major summits feature both a professional clinical academic forum, where leading experts convene to discuss the most cutting-edge clinical research, and an enterprise innovation forum, which explores the application and R&D directions of new technologies, as well as market dynamics and competitive strategies. This dual approach facilitates true peak-level interaction and seamless integration among industry, academia, and research.
Science and technology know no borders. The development of the global healthcare industry relies on the integration and exchange of worldwide technological advancements. This forum served as a bridge, linking capital with talent, domestic with international stakeholders, and industry with clinical practice through an open-minded approach. It created value by fostering the integration of industry, academia, and research, and drove industrial progress by facilitating connections between capital and talent.
Novel formats, fresh perspectives, and a new platform were also prominent highlights of this forum. The Internet has enabled borderless communication. Guided by the vision of fostering industrial integration, international exchange, and economic development, the forum was organized to embody the principle that “connections create opportunities, and opportunities generate value.” Furthermore, the newly built platform incorporated various interactive elements, making all sessions open and engaging. Over the course of five days, attendees could enjoy the conferences in a relaxed and lively atmosphere while gaining substantial, practical insights.
Amid the COVID-19 pandemic, this summit is a large-scale international online communication platform established by Hillhouse Capital, Mayo Clinic, and Huimei Healthcare, overcoming the temporal and spatial differences among global participants.https://hillhousecare.com/）。
This summit has pioneered the integration of three core functions—academic training, interactive discussions, and exhibitions—all conducted online. This approach creates more opportunities for in-depth exchange and dialogue among attendees and enterprises, while also enabling a comprehensive and lasting digital record of the summit’s highlights.
The conference spanned approximately one week, featuring 40 lectures and 16 live broadcasts, all delivered in bilingual format. Dozens of prominent domestic and international experts participated. The content covered a wide range of topics, including personalized medicine, patient management systems, breast cancer prevention and treatment frameworks, new approaches to respiratory disease prevention and control, medical big data and AI, healthcare quality control and payment reforms, cell and immunotherapy, innovative oncology diagnosis and treatment, challenges in the orphan drug market, basic scientific research on COVID-19, RNA and mRNA therapies, and gene therapy. These topics encompassed various sectors such as healthcare, insurance, pharmaceutical enterprises, and social security, fully reflecting the integration and interaction among industry, academia, research, and clinical practice.
Features such as online material downloads, virtual booth tours, and digital business card exchanges enable the online conference to replicate the functionalities of an in-person event. For attendees, this approach not only enhances the immersive experience akin to offline participation but also allows them to acquire knowledge and insights from multiple parallel forums simultaneously, thereby expanding their professional networks across different sessions.
Furthermore, this summit will serve as one of Mayo Clinic’s training programs in China. Attendees who complete a specified number of hours of academic lectures will be awarded an official training certificate by Mayo Clinic. The opportunity to engage in professional exchange while earning a training certificate from a world-leading medical institution is not merely an unexpected bonus, but rather reflects the core mission shared by both premier events: to deliver superior healthcare and wellness to the Chinese people through continuous learning and relentless effort. This commitment will remain the enduring goal of the Hillhouse HCare Global Health Industry Summit and the Mayo Clinic China Healthcare Summit.
Unlike traditional academic conferences, the Hillhouse HCare Global Health Industry Summit places greater emphasis on the commercialization of cutting-edge innovations. In addition to addressing topics closely aligned with market concerns, the summit invites as speakers founders of leading global companies at the forefront of emerging industries. For instance, the event featured Dr. Rick Klausner, co-founder of Juno Therapeutics, a pioneer in cell therapy, as well as CEOs from Chinese companies engaged in the development of therapeutic antibodies and vaccines for COVID-19, such as Abogen Biosciences (Suzhou), Clover Biopharmaceuticals, and Junshi Biosciences. These forums featured presentations by industry-leading companies on their R&D progress, with their advancements in commercializing innovations representing the highest standards in their respective subsectors.
As the host of this summit, Hillhouse Capital is one of Asia’s largest investment institutions by assets under management (AUM), with over RMB 500 billion in fund assets.
It is worth noting that Hillhouse Capital has maintained a long-term commitment to investing in the healthcare sector, deeply cultivating the broader health industry. Data shows that Hillhouse Capital has cumulatively invested in over 160 companies in the global healthcare industry, including more than 100 domestic enterprises and over 60 overseas enterprises, covering nearly all sub-sectors of the medical industry.
Leveraging Hillhouse Capital’s overarching influence in the healthcare sector, Hillhouse will utilize the “Hillhouse HCare Global Healthcare Industry Summit & Mayo Clinic China Medical Summit” to establish an international exchange platform, convene top-tier industry leaders, and foster integrated innovation and industrial prosperity.
Led by Hillhouse, Join the Dialogue on Healthcare. From August 6 to August 10, 2020, the Hillhouse HCare Global Health Industry Summit & Mayo Clinic China Healthcare Summit invites you to engage in thought-provoking discussions and advocate for “Health.”
The official registration portal for the Hillhouse HCare Global Health Industry Summit is now live. Simply click “Register Now” to secure your spot at this premier event in the global health sector, taking place in one month.
1. Registration URL: https://hillhousecare.com/
2. Scan the QR code:
Highlights from Previous Editions:
In 2015, Hillhouse Capital partnered with the Mayo Clinic, revered as the “Mecca” of the medical world, to jointly establish Huimei Healthcare, initiating a systematic effort to disseminate the Mayo Clinic’s knowledge and philosophy in China.
Infographic: Highlights from the Inaugural Mayo Clinic China Hospital Management Summit in 2017
The inaugural Mayo Clinic China Hospital Management Summit was grandly held in Beijing on April 21–22, 2017. More than 400 elites from the medical community gathered for the event. For the first time, Mayo Clinic dispatched a large-scale faculty team to share with Chinese hospital administrators its mature models and successful experiences in core areas, including brand building, care delivery models, hospital management, world-class hospital IT systems, and patient services. The theme “Learning Management from the World’s Best Hospital” became one of the most frequently mentioned buzzwords at the summit.
Infographic: Highlights from the 2nd Mayo Clinic China Hospital Management Summit in 2018
From June 1 to 2, 2018, the 2nd Mayo Clinic China Hospital Management Summit was grandly held in Shanghai. More than 500 medical elites gathered for the event, which was themed “Technology · Experience · Innovation.” The summit facilitated comprehensive exchanges of concepts and practical experiences, focusing on the hopes and applications brought by technology, best medical practices and patient experience, as well as refined management and innovation. Hundreds of domestic and international medical leaders jointly witnessed the collision and integration of top-tier healthcare management philosophies from China and the United States.
Infographic: Highlights from the 3rd Mayo Clinic China Hospital Management Summit in 2019
April 12–13, 2019: The 3rd Mayo Clinic China Hospital Management Summit was grandly held in Beijing. Bringing together high-quality resources from all sectors, the summit focused on “Frontiers · Transformation · Resources.” Leveraging a global academic vantage point, it invited numerous top medical leaders from China and the United States to discuss cutting-edge topics in the global healthcare industry, ranging from specialty frontiers, translational medicine, and advanced technologies to payment model reforms and overall strategic planning. With attendance exceeding 1,000 participants, the event was unprecedented in its scale and success.